Coloplast presents strong Q3 figures
The Danish medtech firm has just released its third quarterly report for fiscal 2021/2022, maintaining it full-year guidance while beating analysts’ expectations. (Updated)
by mikkel holmgaard winding, translated by daniel pedersen
In the third quarter of financial 2021/2022, Coloplast managed to exceed expectations set by analysts prior to the report.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast is phasing out natural gas
For subscribers
Smith & Nephew exits tough half year
For subscribers
